Scalpel Weekly News

Week of: September 19, 2016

IN THE NEWS


Traumatic Brain Injury; FDA Promotes Development of Diagnostics and Treatments

Expanding on its recent approval of two new devices to assess a patient’s cognitive function immediately after a suspected brain injury or concussion, on September 8, 2016 the FDA described how it is researching traumatic brain injury (TBI) and encouraging the development of new medical devices to help diagnose and treat it. A sudden movement of the head and brain can cause the brain to bounce or twist in the skull, stretching and injuring brain cells and creating chemical changes. This damage is called a traumatic brain injury (TBI). Click title to continue reading...


 
MEDICAL ALERTS


Hypoglycemia Kit Recalled; Detached Needles on Syringe; Serious Injury Possible

On September 9, 2016, Novo Nordisk Inc. recalled six batches of the GlucaGen HypoKit (glucagon [rDNA origin] for injection) in the U.S. due to two customer complaints from the UK and Portugal involving detached needles on the syringe with Sterile Water for Injection (SWFI). Click title to continue reading...



FDA Recommends Against Use of Ovarian Cancer Screening Tests

On September 7, 2016, the FDA alerted women about the risks associated with the use of tests being marketed as ovarian cancer screening tests. The FDA is especially concerned about delaying effective preventive treatments for women who show no symptoms, but who are still at increased risk for developing ovarian cancer. Click title to continue reading...



Poor Blood Pressure Control Puts Five Million at Risk

Some five million Medicare Part D enrollees age 65 and older are not taking their blood pressure medicine properly, increasing their risk of heart disease, stroke, kidney disease, and death, according to a new report released on September 13, 2016, by the CDC. Medicare Part D is a federal program that helps Medicare beneficiaries with the costs of prescription drugs and prescription drug insurance premiums. Click title to continue reading...


  CASE ALERTS


Transvaginal Mesh; New Trial Due to Exclusion of Medical Application Caution, FDA Letters

A woman sought medical care for pelvic organ prolapse (POP) symptoms involving her bladder. Specifically, she experienced a bulging sensation in her pelvic area. She underwent a surgical repair involving a medical device known as a pelvic floor repair kit. During the procedure a mesh device was permanently implanted in her pelvic cavity to shore up weakened tissue. Click title to continue reading...



Med Mal Complaint Dismissed; Failed to Submit Expert Similar to Emergency Providers

A man presented to the hospital with air in his lungs. He was admitted for treatment at a hospital where an emergency room physician rendered care. He was subsequently transferred to another hospital where a second emergency room physician rendered care. The man later died. Click title to continue reading...



Insurer’s Denial of Skilled Nursing Care Coverage Found Frivolous

A woman was a patient at a skilled nursing facility (SNF) for about three months. About a month prior to her discharge, the woman had a home evaluation. Her occupational therapist did not recommend that the woman return home at that time. The woman received occupational and physical therapy for another week. At that point, a physician ordered occupational therapy five days a week for a period of 30 days.  Click title to continue reading...


FEATURE


Motion to Strike Expert: Breast Reconstruction

As a special feature for our Premium subscribers we have included this feature containing an illustrative defendants’Motion to Strike Expert to prevent the testimony of the plaintiff’s plastic surgeon expert in this malpractice action involving the plaintiff’s breast reconstruction using the TRAM flap procedure. The plaintiff’s action is based on lack of informed consent, that she was not told of alternatives to the TRAM flap procedure. Click title to continue reading...